Developing an Effective Validation Strategy in Pharmaceutical Production

A well-defined validation strategy is crucial in the pharmaceutical sector. It ensures that equipment, processes, utilities, and cleaning methods are appropriate for their intended purposes and remain under control throughout their operational lifespan. This strategy encompasses various questions regarding what needs validation, the rationale behind it, the evidence required, and the guidelines to follow.

Creating a validation strategy is not simply about listing tasks in a validation master plan (VMP); it involves integrating comprehensive knowledge of the product and process with Quality Risk Management principles, qualification evaluations, and validation testing.

Formulating the Strategy Based on Risk Assessment

When developing a validation strategy, a thorough understanding of the product, production methods, and potential failure modes is essential. The validation team identifies critical quality attributes, essential production parameters, material characteristics, equipment functionality, and system controls that could impact product quality. Risk assessment plays a vital role in pinpointing where evidence is most necessary and determining the extent of qualification and validation required. For example, a change in a product-contact mixer could significantly affect cleaning processes and mixing efficiency. In contrast, alterations to a non-product-contact printer are unlikely to have such ramifications.

The risk assessment should factor in elements such as patient safety, product characteristics, process complexity, prior experiences, and equipment design. The ICH Q9(R1) guidelines provide valuable tools for implementing quality risk management throughout the product lifecycle.

Creating a Validation Master Plan

A Validation Master Plan (VMP) outlines the overarching framework for qualification and validation activities within a facility. It should clearly articulate the responsibilities, priorities, and current validation status across various systems and processes, including:

• Facilities and utilities, such as HVAC and pharmaceutical water
• Manufacturing and packaging equipment
• Process validation and ongoing processing verification
• Cleaning validation
• Validation of analytical methods
• Sterilization and aseptic processing validation
• Computerized systems and automation
• Transport and time studies

The VMP must encompass all relevant systems and processes, detailing procedures, responsibilities, and outstanding qualification or validation plans. A common pitfall is maintaining a VMP that merely lists equipment and procedures without reflecting the current status of the facility. It should be a dynamic management document, excluding retired equipment, incorporating new systems, and addressing overdue activities and changes.

Choosing the Appropriate Validation Method

The selected validation approach must align with the subject matter's validity and the methods employed for demonstration. The FDA's lifecycle model outlines three stages for process validation:

1. Process Design: Utilising knowledge from development and scale-up processes to define the intended commercial processes.
2. Process Qualification: Evaluating the plant, equipment, utilities, and manufacturing processes to confirm the ability to produce consistently.
3. Continued Process Verification: Collecting and analysing regular production data to ensure process control.

Other validation types, such as cleaning validation, require consideration of scientifically supported acceptable residue limits and sampling methods. For computerized systems, key factors include intended use, functionality, and associated risks. Utility qualification should also be based on suitable evidence for the utility's application.

Establishing Evidence Prior to Execution

A sound validation strategy specifies the evidence to be collected before commencing work. Standard procedures should delineate the assessment scope, responsibilities, prerequisites, testing instruments, sampling schemes, and approval protocols. Preconditions may encompass operational manuals, responsive devices, appropriate testing instruments, trained personnel, and relevant analysis methods.

Sampling should adequately represent the risks and variations under investigation. For process qualification, it is essential to capture various production cycle stages and necessary working conditions. Cleaning validation must address hard-to-clean areas and appropriate sampling techniques. Approval protocols should include scientific justification for the required approval levels. If a study does not meet approval criteria, an investigation must follow to understand the implications.

Linking Changes and Deviations to Validation

Validation status may be compromised by changes occurring after the initial validation study. Modifications to formulas, raw materials, equipment, software, manufacturing parameters, facilities, and cleaning procedures necessitate a change control assessment. This evaluation should determine if the change impacts validated assumptions, product quality, or process capability, and whether additional qualification or validation is warranted. The required actions may range from documented justification without testing to focused studies or comprehensive re-validation.

Deviations during qualification or validation must also be scrutinised. A deviation affecting a critical parameter cannot be disregarded solely because the final product meets specifications. It is essential to analyse the data, assess potential impacts on product quality and reproducibility, and evaluate whether the protocol remains adequate.

Ensuring Continued Validity After Approval

The validation report marks the initiation of a new strategy. Ongoing monitoring is crucial to ensure meaningful changes in process efficiency and system stability. Relevant information to track may include batch trends, deviations, out-of-specification results, complaints, calibration failures, maintenance logs, cleaning records, environmental monitoring outcomes, audit trails, and the effectiveness of corrective and preventive actions.

Periodic reviews will gather sufficient evidence to verify whether the original validation assumptions hold true. Re-qualification or re-validation should be based on requirements, historical practices, and risk assessments rather than fixed time intervals. Quality assurance professionals must be prepared to demonstrate that the current validation state remains active, particularly when questioned by inspectors regarding long-term process control.

Key Components of an Effective Validation Strategy

A robust strategy interlinks the VMP, risk assessments, qualification documents, validation SOPs, reports, change controls, and monitoring activities. Each document must convey a consistent narrative regarding risk identification, control demonstration, and the maintenance of control processes. A common weakness in validation strategies is fragmentation, where different departments manage various aspects without a holistic view. Clear responsibilities and cross-functional reviews can help mitigate this issue.

The effectiveness of a validation strategy can be measured by the quality of decisions it produces. A company that can articulate the reasoning behind each action and support it with adequate evidence will integrate validation into its quality system, making it a vital component rather than a mere checklist of completed tasks.